Prediction of Outcomes After Surgery for Unruptured Intracranial Aneurysms

Trial ID or NCT#

NCT04819074

Status

not recruiting iconNOT RECRUITING

Purpose

Accurate preoperative identification of patients at high risk for adverse outcomes would be clinically advantageous, as it would allow enhanced resource preparation, better surgical decision-making, enhanced patient education and informed consent, and potentially even modification of certain modifiable risk factors. The aim of the Prediction of adverse events after microsurgery for intracranial unruptured aneurysms (PRAEMIUM) study is therefore to develop and externally validate a clinically applicable, robust ML-based prediction tool based on multicenter data from a range of international centers.

Official Title

The Prediction of Adverse Events After Microsurgery for Intracranial Unruptured Aneurysms (PRAEMIUM) Study

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. * Adult patients (18 or older)* Undergone microsurgical treatment for unruptured intracranial aneurysm* Patients with prior SAH may only be included when surgical treatment occurred at least 4 weeks after ictus.* Treated from January 1st 2010 onwards
Exclusion Criteria:
  1. * No specific exclusion criteria
View All Criteria
Show Less

Investigator(s)

Gary K. Steinberg, MD, PhD
Gary K. Steinberg, MD, PhD
Cerebrovascular neurosurgeon, Moyamoya surgeon, Aneurysm neurosurgeon, Neurosurgeon, Neurosurgeon
Bernard and Ronni Lacroute-William Randolph Hearst Professor of Neurosurgery and Neurosciences and Professor, by courtesy, of Neurology

Contact us to find out if this trial is right for you.

Contact

Gary K Steinberg

View on ClinicalTrials.gov